We are live on
!
Find out more
FWM
Frontier Wealth Management Portfolio holdings
AUM
$1.38B
1-Year Est. Return
6.3%
This Fund
S&P 500
This Quarter
Est. Return
+3%
1 Year Est. Return
+6.3%
3 Year Est. Return
+42.77%
5 Year Est. Return
+78.1%
10 Year Est. Return
–
AUM
$650M
AUM Growth
+$27.3M
(+4.4%)
Cap. Flow
+$12.3B
Cap. Flow
% of AUM
1,897.25%
Top 10 Holdings %
Top 10 Hldgs %
33.36%
Holding
398
New
90
Increased
136
Reduced
97
Closed
54
Top Buys
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$12.3B |
| 2 |
Gilead Sciences
GILD
|
+$8.42M |
| 3 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$7.41M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$6.28M |
| 5 |
Amgen
AMGN
|
+$5.76M |
Top Sells
| 1 |
General Mills
GIS
|
+$66.6M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$13.4M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$9.19M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$8.15M |
| 5 |
IFLN
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
|
+$4.97M |
Sector Composition
| 1 | Energy | 18% |
| 2 | Healthcare | 10.47% |
| 3 | Technology | 5.62% |
| 4 | Consumer Staples | 4.01% |
| 5 | Consumer Discretionary | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
GeoPark
GPRK
$618M
| $90.4M | 13.91% |
19,228,333
+69,757
| +0.4% | +$352K |
|
2
Invesco FTSE RAFI US 1000 ETF
PRF
$9.81B
| $20.5M | 3.15% |
1,129,730
-33,335
| -3% | -$619K |
|
3
iShares MBS ETF
MBB
$39.3B
| $16.6M | 2.55% |
152,643
-5,438
| -3% | -$596K |
|
4
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.8B
| $16M | 2.47% |
772,340
+10,160
| +1% | +$213K |
|
5
Schwab International Equity ETF
SCHF
$65.7B
| $15.8M | 2.43% |
1,037,710
-4,066
| -0.4% | -$63.9K |
|
|
6
Schwab Short-Term US Treasury ETF
SCHO
$12.7B
| $14.3M | 2.19% |
562,102
+292,260
| +108% | +$7.41M |
|
7
Procter & Gamble
PG
$353B
| $11.6M | 1.78% |
147,622
+8,917
| +6% | +$718K |
|
8
Apple
AAPL
$4.89T
| $10.9M | 1.68% |
348,960
+159,740
| +84% | +$5.11M |
|
9
Schwab US TIPS ETF
SCHP
$16.5B
| $10.5M | 1.61% |
385,822
+210,698
| +120% | +$5.76M |
|
|
SCHR
10
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $10.3M | 1.59% |
386,042
+184,904
| +92% | +$4.99M |
|
|
11
Gilead Sciences
GILD
$169B
| $9.58M | 1.47% |
81,845
+77,053
| +1,608% | +$8.42M |
|
12
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
| $8.98M | 1.38% |
220,617
+5,550
| +3% | +$236K |
|
13
Vanguard Short-Term Bond ETF
BSV
$44.7B
| $8.82M | 1.36% |
110,014
-2,743
| -2% | -$220K |
|
14
Vanguard Intermediate-Term Bond ETF
BIV
$29B
| $8.58M | 1.32% |
102,316
-2,200
| -2% | -$187K |
|
|
15
Berkshire Hathaway Class A
BRK.A
$1.06T
| $8.42M | 1.3% |
57,438
+57,434
| +1,435,850% | +$12.3B |
|
16
iShares 20+ Year Treasury Bond ETF
TLT
$41.9B
| $7.86M | 1.21% |
66,893
+34,584
| +107% | +$4.24M |
|
17
Vanguard Real Estate ETF
VNQ
$39.7B
| $6.76M | 1.04% |
90,563
-798
| -0.9% | -$63.8K |
|
18
Schwab Emerging Markets Equity ETF
SCHE
$12.5B
| $6.58M | 1.01% |
267,803
-2,048
| -0.8% | -$52.4K |
|
|
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.45M | 0.99% |
+73,345
| New | +$6.28M |
|
|
20
Amgen
AMGN
$201B
| $6.38M | 0.98% |
41,573
+35,973
| +642% | +$5.76M |
|
21
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$349M
| $6.32M | 0.97% |
224,679
+6,793
| +3% | +$194K |
|
22
Vanguard Long-Term Bond ETF
BLV
$5.84B
| $6.24M | 0.96% |
71,268
-815
| -1% | -$74.6K |
|
23
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
| $5.63M | 0.87% |
76,345
-3,742
| -5% | -$282K |
|
|
CELG
24
DELISTED
Celgene Corp
CELG
| $5.27M | 0.81% |
45,571
+43,042
| +1,702% | +$4.92M |
|
25
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
| $5.2M | 0.8% |
47,279
-5,872
| -11% | -$657K |
|
Similar funds
AWM
AP
BDWM
DHFB
MCM
RE
TFM
MWM